APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ophthalmology Therapeutics

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Ophthalmology Therapeutics Industry Growth and Trends Forecast to 2032

20 December 2025106 pages

Choose your research edition.

Industry ResearchOphthalmology Therapeutics Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Ophthalmology Therapeutics Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Ophthalmology Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ophthalmology Therapeutics Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Ophthalmology Therapeutics Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Ophthalmology Therapeutics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Ophthalmology Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Ophthalmology Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ophthalmology Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ophthalmology Therapeutics include Teva Pharmaceutical Industries, Novartis AG, Pfizer, Santen Pharmaceutical, Bayer, AbbVie, Regeneron Pharmaceuticals, Otsuka Holdings and F. Hoffmann-La Roche, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Ophthalmology Therapeutics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Ophthalmology Therapeutics market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Ophthalmology Therapeutics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Ophthalmology Therapeutics.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Ophthalmology Therapeutics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Ophthalmology Therapeutics Market by Company

Teva Pharmaceutical Industries

Novartis AG

Pfizer

Santen Pharmaceutical

Bayer

AbbVie

Regeneron Pharmaceuticals

Otsuka Holdings

F. Hoffmann-La Roche

Aerie Pharmaceuticals

Ophthalmology Therapeutics Segment by Type

Ointments

Eye Solutions

Gels

Capsules & Tablets

Ophthalmology Therapeutics Segment by Application

Eye Infection

Glaucoma

Dry Eye Syndrome

Other

Ophthalmology Therapeutics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ophthalmology Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ophthalmology Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ophthalmology Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Ophthalmology Therapeutics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Ophthalmology Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Ointments Table 2. Major Company of Eye Solutions Table 3. Major Company of Gels Table 4. Major Company of Capsules & Tablets Table 5. Global Ophthalmology Therapeutics Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Ophthalmology Therapeutics Sales by Type (2021-2026) & (k units) Table 7. Global Ophthalmology Therapeutics Sales Market Share in Volume by Type (2021-2026) Table 8. Global Ophthalmology Therapeutics Sales by Type (2021-2026) & (US$ Million) Table 9. Global Ophthalmology Therapeutics Sales Market Share in Value by Type (2021-2026) Table 10. Global Ophthalmology Therapeutics Price by Type (2021-2026) & (US$/unit) Table 11. Global Ophthalmology Therapeutics Sales by Type (2027-2032) & (k units) Table 12. Global Ophthalmology Therapeutics Sales Market Share in Volume by Type (2027-2032) Table 13. Global Ophthalmology Therapeutics Sales by Type (2027-2032) & (US$ Million) Table 14. Global Ophthalmology Therapeutics Sales Market Share in Value by Type (2027-2032) Table 15. Global Ophthalmology Therapeutics Price by Type (2027-2032) & (US$/unit) Table 16. North America Ophthalmology Therapeutics Sales by Type (2021-2026) & (k units) Table 17. North America Ophthalmology Therapeutics Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Ophthalmology Therapeutics Sales by Type (2021-2026) & (k units) Table 19. Europe Ophthalmology Therapeutics Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Ophthalmology Therapeutics Sales by Type (2021-2026) & (k units) Table 21. Asia-Pacific Ophthalmology Therapeutics Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Ophthalmology Therapeutics Sales by Type (2021-2026) & (k units) Table 23. Latin America Ophthalmology Therapeutics Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Ophthalmology Therapeutics Sales by Type (2021-2026) & (k units) Table 25. Middle East and Africa Ophthalmology Therapeutics Sales by Type (2021-2026) & (US$ Million) Table 26. Ophthalmology Therapeutics Industry Trends Table 27. Ophthalmology Therapeutics Industry Drivers Table 28. Ophthalmology Therapeutics Industry Opportunities and Challenges Table 29. Ophthalmology Therapeutics Industry Restraints Table 30. Global Ophthalmology Therapeutics Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Ophthalmology Therapeutics Revenue Market Share by Company (2021-2026) Table 32. Global Ophthalmology Therapeutics Sales by Company (2021-2026) & (k units) Table 33. Global Ophthalmology Therapeutics Sales Share by Company (2021-2026) Table 34. Global Ophthalmology Therapeutics Market Price by Company (2021-2026) & (US$/unit) Table 35. Global Ophthalmology Therapeutics Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Ophthalmology Therapeutics Major Company Production Sites and Headquarters Table 37. Global Ophthalmology Therapeutics Company, Product Type & Application Table 38. Global Ophthalmology Therapeutics Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Ophthalmology Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Ophthalmology Therapeutics Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Ophthalmology Therapeutics Sales by Region (2021-2026) & (k units) Table 43. Global Ophthalmology Therapeutics Sales Market Share in Volume by Region (2021-2026) Table 44. Global Ophthalmology Therapeutics Sales by Region (2021-2026) & (US$ Million) Table 45. Global Ophthalmology Therapeutics Sales Market Share in Value by Region (2021-2026) Table 46. Global Ophthalmology Therapeutics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 47. Global Ophthalmology Therapeutics Sales by Region (2027-2032) & (k units) Table 48. Global Ophthalmology Therapeutics Sales Market Share in Volume by Region (2027-2032) Table 49. Global Ophthalmology Therapeutics Sales by Region (2027-2032) & (US$ Million) Table 50. Global Ophthalmology Therapeutics Sales Market Share in Value by Region (2027-2032) Table 51. Global Ophthalmology Therapeutics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 52. Global Ophthalmology Therapeutics Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Ophthalmology Therapeutics Sales by Application (2021-2026) & (k units) Table 54. Global Ophthalmology Therapeutics Sales Market Share in Volume by Application (2021-2026) Table 55. Global Ophthalmology Therapeutics Sales by Application (2021-2026) & (US$ Million) Table 56. Global Ophthalmology Therapeutics Sales Market Share in Value by Application (2021-2026) Table 57. Global Ophthalmology Therapeutics Price by Application (2021-2026) & (US$/unit) Table 58. Global Ophthalmology Therapeutics Sales by Application (2027-2032) & (k units) Table 59. Global Ophthalmology Therapeutics Sales Market Share in Volume by Application (2027-2032) Table 60. Global Ophthalmology Therapeutics Sales by Application (2027-2032) & (US$ Million) Table 61. Global Ophthalmology Therapeutics Sales Market Share in Value by Application (2027-2032) Table 62. Global Ophthalmology Therapeutics Price by Application (2027-2032) & (US$/unit) Table 63. North America Ophthalmology Therapeutics Sales by Application (2021-2026) & (k units) Table 64. North America Ophthalmology Therapeutics Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Ophthalmology Therapeutics Sales by Application (2021-2026) & (k units) Table 66. Europe Ophthalmology Therapeutics Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Ophthalmology Therapeutics Sales by Application (2021-2026) & (k units) Table 68. Asia-Pacific Ophthalmology Therapeutics Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Ophthalmology Therapeutics Sales by Application (2021-2026) & (k units) Table 70. Latin America Ophthalmology Therapeutics Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Ophthalmology Therapeutics Sales by Application (2021-2026) & (k units) Table 72. Middle East and Africa Ophthalmology Therapeutics Sales by Application (2021-2026) & (US$ Million) Table 73. Teva Pharmaceutical Industries Company Information Table 74. Teva Pharmaceutical Industries Business Overview Table 75. Teva Pharmaceutical Industries Ophthalmology Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Teva Pharmaceutical Industries Ophthalmology Therapeutics Product Portfolio Table 77. Teva Pharmaceutical Industries Recent Development Table 78. Novartis AG Company Information Table 79. Novartis AG Business Overview Table 80. Novartis AG Ophthalmology Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Novartis AG Ophthalmology Therapeutics Product Portfolio Table 82. Novartis AG Recent Development Table 83. Pfizer Company Information Table 84. Pfizer Business Overview Table 85. Pfizer Ophthalmology Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Pfizer Ophthalmology Therapeutics Product Portfolio Table 87. Pfizer Recent Development Table 88. Santen Pharmaceutical Company Information Table 89. Santen Pharmaceutical Business Overview Table 90. Santen Pharmaceutical Ophthalmology Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Santen Pharmaceutical Ophthalmology Therapeutics Product Portfolio Table 92. Santen Pharmaceutical Recent Development Table 93. Bayer Company Information Table 94. Bayer Business Overview Table 95. Bayer Ophthalmology Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Bayer Ophthalmology Therapeutics Product Portfolio Table 97. Bayer Recent Development Table 98. AbbVie Company Information Table 99. AbbVie Business Overview Table 100. AbbVie Ophthalmology Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. AbbVie Ophthalmology Therapeutics Product Portfolio Table 102. AbbVie Recent Development Table 103. Regeneron Pharmaceuticals Company Information Table 104. Regeneron Pharmaceuticals Business Overview Table 105. Regeneron Pharmaceuticals Ophthalmology Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Regeneron Pharmaceuticals Ophthalmology Therapeutics Product Portfolio Table 107. Regeneron Pharmaceuticals Recent Development Table 108. Otsuka Holdings Company Information Table 109. Otsuka Holdings Business Overview Table 110. Otsuka Holdings Ophthalmology Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Otsuka Holdings Ophthalmology Therapeutics Product Portfolio Table 112. Otsuka Holdings Recent Development Table 113. F. Hoffmann-La Roche Company Information Table 114. F. Hoffmann-La Roche Business Overview Table 115. F. Hoffmann-La Roche Ophthalmology Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. F. Hoffmann-La Roche Ophthalmology Therapeutics Product Portfolio Table 117. F. Hoffmann-La Roche Recent Development Table 118. Aerie Pharmaceuticals Company Information Table 119. Aerie Pharmaceuticals Business Overview Table 120. Aerie Pharmaceuticals Ophthalmology Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 121. Aerie Pharmaceuticals Ophthalmology Therapeutics Product Portfolio Table 122. Aerie Pharmaceuticals Recent Development Table 123. North America Ophthalmology Therapeutics Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 124. North America Ophthalmology Therapeutics Sales by Country (2021-2026) & (k units) Table 125. North America Ophthalmology Therapeutics Sales Market Share by Country (2021-2026) Table 126. North America Ophthalmology Therapeutics Sales Forecast by Country (2027-2032) & (k units) Table 127. North America Ophthalmology Therapeutics Sales Market Share Forecast by Country (2027-2032) Table 128. North America Ophthalmology Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America Ophthalmology Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 130. North America Ophthalmology Therapeutics Market Share by Country (2021-2026) Table 131. North America Ophthalmology Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America Ophthalmology Therapeutics Market Share Forecast by Country (2027-2032) Table 133. Europe Ophthalmology Therapeutics Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 134. Europe Ophthalmology Therapeutics Sales by Country (2021-2026) & (k units) Table 135. Europe Ophthalmology Therapeutics Sales Market Share by Country (2021-2026) Table 136. Europe Ophthalmology Therapeutics Sales Forecast by Country (2027-2032) & (k units) Table 137. Europe Ophthalmology Therapeutics Sales Market Share Forecast by Country (2027-2032) Table 138. Europe Ophthalmology Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Europe Ophthalmology Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 140. Europe Ophthalmology Therapeutics Market Share by Country (2021-2026) Table 141. Europe Ophthalmology Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Europe Ophthalmology Therapeutics Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Ophthalmology Therapeutics Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Ophthalmology Therapeutics Sales by Country (2021-2026) & (k units) Table 145. Asia-Pacific Ophthalmology Therapeutics Sales Market Share by Country (2021-2026) Table 146. Asia-Pacific Ophthalmology Therapeutics Sales Forecast by Country (2027-2032) & (k units) Table 147. Asia-Pacific Ophthalmology Therapeutics Sales Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Ophthalmology Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Ophthalmology Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Ophthalmology Therapeutics Market Share by Country (2021-2026) Table 151. Asia-Pacific Ophthalmology Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Ophthalmology Therapeutics Market Share Forecast by Country (2027-2032) Table 153. Latin America Ophthalmology Therapeutics Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 154. Latin America Ophthalmology Therapeutics Sales by Country (2021-2026) & (k units) Table 155. Latin America Ophthalmology Therapeutics Sales Market Share by Country (2021-2026) Table 156. Latin America Ophthalmology Therapeutics Sales Forecast by Country (2027-2032) & (k units) Table 157. Latin America Ophthalmology Therapeutics Sales Market Share Forecast by Country (2027-2032) Table 158. Latin America Ophthalmology Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Latin America Ophthalmology Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 160. Latin America Ophthalmology Therapeutics Market Share by Country (2021-2026) Table 161. Latin America Ophthalmology Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Latin America Ophthalmology Therapeutics Market Share Forecast by Country (2027-2032) Table 163. Middle East and Africa Ophthalmology Therapeutics Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 164. Middle East and Africa Ophthalmology Therapeutics Sales by Country (2021-2026) & (k units) Table 165. Middle East and Africa Ophthalmology Therapeutics Sales Market Share by Country (2021-2026) Table 166. Middle East and Africa Ophthalmology Therapeutics Sales Forecast by Country (2027-2032) & (k units) Table 167. Middle East and Africa Ophthalmology Therapeutics Sales Market Share Forecast by Country (2027-2032) Table 168. Middle East and Africa Ophthalmology Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Middle East and Africa Ophthalmology Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 170. Middle East and Africa Ophthalmology Therapeutics Market Share by Country (2021-2026) Table 171. Middle East and Africa Ophthalmology Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Middle East and Africa Ophthalmology Therapeutics Market Share Forecast by Country (2027-2032) Table 173. Key Raw Materials Table 174. Raw Materials Key Suppliers Table 175. Ophthalmology Therapeutics Distributors List Table 176. Ophthalmology Therapeutics Customers List Table 177. Research Programs/Design for This Report Table 178. Authors List of This Report Table 179. Secondary Sources Table 180. Primary Sources List of Figures Figure 1. Ophthalmology Therapeutics Image Figure 2. Global Ophthalmology Therapeutics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ophthalmology Therapeutics Market Size (2021-2032) & (US$ Million) Figure 4. Global Ophthalmology Therapeutics Sales (2021-2032) & (k units) Figure 5. Ointments Image Figure 6. Global Ointments Sales YoY Growth (2021-2032) & (k units) Figure 7. Eye Solutions Image Figure 8. Global Eye Solutions Sales YoY Growth (2021-2032) & (k units) Figure 9. Gels Image Figure 10. Global Gels Sales YoY Growth (2021-2032) & (k units) Figure 11. Capsules & Tablets Image Figure 12. Global Capsules & Tablets Sales YoY Growth (2021-2032) & (k units) Figure 13. Global Ophthalmology Therapeutics Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Ophthalmology Therapeutics Market Share by Type 2025 VS 2032 Figure 15. North America Ophthalmology Therapeutics Sales Market Share in Volume by Type in 2025 Figure 16. North America Ophthalmology Therapeutics Sales Market Share in Value by Type in 2025 Figure 17. Europe Ophthalmology Therapeutics Sales Market Share in Volume by Type in 2025 Figure 18. Europe Ophthalmology Therapeutics Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Ophthalmology Therapeutics Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Ophthalmology Therapeutics Sales Market Share in Value by Type in 2025 Figure 21. Latin America Ophthalmology Therapeutics Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Ophthalmology Therapeutics Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Ophthalmology Therapeutics Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Ophthalmology Therapeutics Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Ophthalmology Therapeutics Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Eye Infection Image Figure 28. Global Eye Infection Sales YoY Growth (2021-2032) & (k units) Figure 29. Glaucoma Image Figure 30. Global Glaucoma Sales YoY Growth (2021-2032) & (k units) Figure 31. Dry Eye Syndrome Image Figure 32. Global Dry Eye Syndrome Sales YoY Growth (2021-2032) & (k units) Figure 33. Other Image Figure 34. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 35. Global Ophthalmology Therapeutics Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Ophthalmology Therapeutics Market Share by Application 2025 VS 2032 Figure 37. North America Ophthalmology Therapeutics Sales Market Share in Volume by Application in 2025 Figure 38. North America Ophthalmology Therapeutics Sales Market Share in Value by Application in 2025 Figure 39. Europe Ophthalmology Therapeutics Sales Market Share in Volume by Application in 2025 Figure 40. Europe Ophthalmology Therapeutics Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Ophthalmology Therapeutics Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Ophthalmology Therapeutics Sales Market Share in Value by Application in 2025 Figure 43. Latin America Ophthalmology Therapeutics Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Ophthalmology Therapeutics Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Ophthalmology Therapeutics Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Ophthalmology Therapeutics Sales Market Share in Value by Application in 2025 Figure 47. North America Ophthalmology Therapeutics Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. North America Ophthalmology Therapeutics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Ophthalmology Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Ophthalmology Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Ophthalmology Therapeutics Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Europe Ophthalmology Therapeutics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Ophthalmology Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Ophthalmology Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Ophthalmology Therapeutics Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Asia-Pacific Ophthalmology Therapeutics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Ophthalmology Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Ophthalmology Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Ophthalmology Therapeutics Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Latin America Ophthalmology Therapeutics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Ophthalmology Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Ophthalmology Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Ophthalmology Therapeutics Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Middle East and Africa Ophthalmology Therapeutics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Ophthalmology Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Ophthalmology Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Ophthalmology Therapeutics Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Ophthalmology Therapeutics Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Ointments
  • Eye Solutions
  • Gels
  • Capsules & Tablets
Applications
  • Eye Infection
  • Glaucoma
  • Dry Eye Syndrome
  • Other
Companies covered
  • Teva Pharmaceutical Industries
  • Novartis AG
  • Pfizer
  • Santen Pharmaceutical
  • Bayer
  • AbbVie
  • Regeneron Pharmaceuticals
  • Otsuka Holdings
  • F. Hoffmann-La Roche
  • Aerie Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ophthalmology Therapeutics Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Ophthalmology Therapeutics Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Ophthalmology Therapeutics Market by Type
  6. 1.3.1 Ointments
  7. 1.3.2 Eye Solutions
  8. 1.3.3 Gels
  9. 1.3.4 Capsules & Tablets
  10. 1.4 Global Ophthalmology Therapeutics Market Size by Type
  11. 1.4.1 Global Ophthalmology Therapeutics Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Ophthalmology Therapeutics Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Ophthalmology Therapeutics Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Ophthalmology Therapeutics Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Ophthalmology Therapeutics Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Ophthalmology Therapeutics Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Ophthalmology Therapeutics Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Ophthalmology Therapeutics Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Ophthalmology Therapeutics Industry Trends
  2. 2.2 Ophthalmology Therapeutics Industry Drivers
  3. 2.3 Ophthalmology Therapeutics Industry Opportunities and Challenges
  4. 2.4 Ophthalmology Therapeutics Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Ophthalmology Therapeutics Revenue (2021-2026)
  2. 3.2 Global Top Players by Ophthalmology Therapeutics Sales (2021-2026)
  3. 3.3 Global Top Players by Ophthalmology Therapeutics Price (2021-2026)
  4. 3.4 Global Ophthalmology Therapeutics Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Ophthalmology Therapeutics Major Company Production Sites & Headquarters
  6. 3.6 Global Ophthalmology Therapeutics Company, Product Type & Application
  7. 3.7 Global Ophthalmology Therapeutics Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Ophthalmology Therapeutics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Ophthalmology Therapeutics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Ophthalmology Therapeutics Tier 1, Tier 2, and Tier 3
4 Ophthalmology Therapeutics Regional Status and Outlook
  1. 4.1 Global Ophthalmology Therapeutics Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Ophthalmology Therapeutics Historic Market Size by Region
  3. 4.2.1 Global Ophthalmology Therapeutics Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Ophthalmology Therapeutics Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Ophthalmology Therapeutics Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Ophthalmology Therapeutics Forecasted Market Size by Region
  7. 4.3.1 Global Ophthalmology Therapeutics Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Ophthalmology Therapeutics Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Ophthalmology Therapeutics Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Ophthalmology Therapeutics by Application
  1. 5.1 Ophthalmology Therapeutics Market by Application
  2. 5.1.1 Eye Infection
  3. 5.1.2 Glaucoma
  4. 5.1.3 Dry Eye Syndrome
  5. 5.1.4 Other
  6. 5.2 Global Ophthalmology Therapeutics Market Size by Application
  7. 5.2.1 Global Ophthalmology Therapeutics Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Ophthalmology Therapeutics Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Ophthalmology Therapeutics Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Ophthalmology Therapeutics Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Ophthalmology Therapeutics Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Ophthalmology Therapeutics Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Ophthalmology Therapeutics Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Ophthalmology Therapeutics Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva Pharmaceutical Industries
  2. 6.1.1 Teva Pharmaceutical Industries Company Information
  3. 6.1.2 Teva Pharmaceutical Industries Business Overview
  4. 6.1.3 Teva Pharmaceutical Industries Ophthalmology Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceutical Industries Ophthalmology Therapeutics Product Portfolio
  6. 6.1.5 Teva Pharmaceutical Industries Recent Developments
  7. 6.2 Novartis AG
  8. 6.2.1 Novartis AG Company Information
  9. 6.2.2 Novartis AG Business Overview
  10. 6.2.3 Novartis AG Ophthalmology Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novartis AG Ophthalmology Therapeutics Product Portfolio
  12. 6.2.5 Novartis AG Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Ophthalmology Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Ophthalmology Therapeutics Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 Santen Pharmaceutical
  20. 6.4.1 Santen Pharmaceutical Company Information
  21. 6.4.2 Santen Pharmaceutical Business Overview
  22. 6.4.3 Santen Pharmaceutical Ophthalmology Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Santen Pharmaceutical Ophthalmology Therapeutics Product Portfolio
  24. 6.4.5 Santen Pharmaceutical Recent Developments
  25. 6.5 Bayer
  26. 6.5.1 Bayer Company Information
  27. 6.5.2 Bayer Business Overview
  28. 6.5.3 Bayer Ophthalmology Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Bayer Ophthalmology Therapeutics Product Portfolio
  30. 6.5.5 Bayer Recent Developments
  31. 6.6 AbbVie
  32. 6.6.1 AbbVie Company Information
  33. 6.6.2 AbbVie Business Overview
  34. 6.6.3 AbbVie Ophthalmology Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 AbbVie Ophthalmology Therapeutics Product Portfolio
  36. 6.6.5 AbbVie Recent Developments
  37. 6.7 Regeneron Pharmaceuticals
  38. 6.7.1 Regeneron Pharmaceuticals Company Information
  39. 6.7.2 Regeneron Pharmaceuticals Business Overview
  40. 6.7.3 Regeneron Pharmaceuticals Ophthalmology Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Regeneron Pharmaceuticals Ophthalmology Therapeutics Product Portfolio
  42. 6.7.5 Regeneron Pharmaceuticals Recent Developments
  43. 6.8 Otsuka Holdings
  44. 6.8.1 Otsuka Holdings Company Information
  45. 6.8.2 Otsuka Holdings Business Overview
  46. 6.8.3 Otsuka Holdings Ophthalmology Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Otsuka Holdings Ophthalmology Therapeutics Product Portfolio
  48. 6.8.5 Otsuka Holdings Recent Developments
  49. 6.9 F. Hoffmann-La Roche
  50. 6.9.1 F. Hoffmann-La Roche Company Information
  51. 6.9.2 F. Hoffmann-La Roche Business Overview
  52. 6.9.3 F. Hoffmann-La Roche Ophthalmology Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 F. Hoffmann-La Roche Ophthalmology Therapeutics Product Portfolio
  54. 6.9.5 F. Hoffmann-La Roche Recent Developments
  55. 6.10 Aerie Pharmaceuticals
  56. 6.10.1 Aerie Pharmaceuticals Company Information
  57. 6.10.2 Aerie Pharmaceuticals Business Overview
  58. 6.10.3 Aerie Pharmaceuticals Ophthalmology Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Aerie Pharmaceuticals Ophthalmology Therapeutics Product Portfolio
  60. 6.10.5 Aerie Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Ophthalmology Therapeutics Sales by Country
  2. 7.1.1 North America Ophthalmology Therapeutics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Ophthalmology Therapeutics Sales by Country (2021-2026)
  4. 7.1.3 North America Ophthalmology Therapeutics Sales Forecast by Country (2027-2032)
  5. 7.2 North America Ophthalmology Therapeutics Market Size by Country
  6. 7.2.1 North America Ophthalmology Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Ophthalmology Therapeutics Market Size by Country (2021-2026)
  8. 7.2.3 North America Ophthalmology Therapeutics Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Ophthalmology Therapeutics Sales by Country
  2. 8.1.1 Europe Ophthalmology Therapeutics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Ophthalmology Therapeutics Sales by Country (2021-2026)
  4. 8.1.3 Europe Ophthalmology Therapeutics Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Ophthalmology Therapeutics Market Size by Country
  6. 8.2.1 Europe Ophthalmology Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Ophthalmology Therapeutics Market Size by Country (2021-2026)
  8. 8.2.3 Europe Ophthalmology Therapeutics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Ophthalmology Therapeutics Sales by Country
  2. 9.1.1 Asia-Pacific Ophthalmology Therapeutics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Ophthalmology Therapeutics Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Ophthalmology Therapeutics Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Ophthalmology Therapeutics Market Size by Country
  6. 9.2.1 Asia-Pacific Ophthalmology Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Ophthalmology Therapeutics Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Ophthalmology Therapeutics Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Ophthalmology Therapeutics Sales by Country
  2. 10.1.1 South America Ophthalmology Therapeutics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Ophthalmology Therapeutics Sales by Country (2021-2026)
  4. 10.1.3 South America Ophthalmology Therapeutics Sales Forecast by Country (2027-2032)
  5. 10.2 South America Ophthalmology Therapeutics Market Size by Country
  6. 10.2.1 South America Ophthalmology Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Ophthalmology Therapeutics Market Size by Country (2021-2026)
  8. 10.2.3 South America Ophthalmology Therapeutics Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Ophthalmology Therapeutics Sales by Country
  2. 11.1.1 Middle East and Africa Ophthalmology Therapeutics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Ophthalmology Therapeutics Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Ophthalmology Therapeutics Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Ophthalmology Therapeutics Market Size by Country
  6. 11.2.1 Middle East and Africa Ophthalmology Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Ophthalmology Therapeutics Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Ophthalmology Therapeutics Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Ophthalmology Therapeutics Value Chain Analysis
  2. 12.1.1 Ophthalmology Therapeutics Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Ophthalmology Therapeutics Production Mode & Process
  7. 12.2 Ophthalmology Therapeutics Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Ophthalmology Therapeutics Distributors
  10. 12.2.3 Ophthalmology Therapeutics Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst